Trial Profile
A retrospective study of teicoplanin maintenance dosing in patients with MRSA bacteraemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Teicoplanin (Primary)
- Indications Bacteraemia; Methicillin-resistant Staphylococcus aureus infections
- Focus Therapeutic Use
- 29 Dec 2015 New trial record